Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and ...
Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and ...
Organ donation after the heart stops beating, a practice called donation after circulatory death, has gone from rare to ...
Organ donation after the heart stops beating, a practice called donation after circulatory death, has gone from rare to ...
Recent advancements in organ procurement techniques to improve the quality of donated organs have given rise to normothermic regional perfusion (NRP), a procedure that restores blood flow to organs in ...
Global ECMO Market OverviewThe global Extracorporeal Membrane Oxygenation market is projected to register steady growth of ...
The meeting will feature sessions on AI in heart failure, advanced LVAD technologies, cardiac xenotransplantation, and more.
Invitation-only program at Houston Methodist, one of the top heart transplant centers in the U.S., highlights the growing need for SynCardia Total Artificial Heart technology. Training initiative at ...
Patent strengthens IP foundation supporting a minimally invasive platform designed to expand access to circulatory ...
“It’s the first time that a patient has successfully gone from a total artificial heart to transplant at the institution,” ...
Q: My best friend was diagnosed with colon cancer at age 48, and I’m recovering from a mild heart attack at age 45. What the heck is going on? We’re ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results